National Reference Laborator y (NRL), par t of Mubadala’s network of world-class healthcare providers and managed by LabCorp®, a world leading life sciences company, providing comprehensive clinical laboratory services, are demonstrating their commitment to continuing medical education for laboratory and other healthcare professionals by their participation in a number of leading healthcare events in the first half of 2017, including two of the largest healthcare events in the world, Arab Health and MEDLAB.
Approximately 70 percent of medical decisions are influenced by laboratory tests, ordered to diagnose, treat, manage, and monitor a patient’s condition, requiring high levels of education and knowledge in order to ensure high quality of services, improved patients outcomes and reducing the unnecessary costs in the industry.
“In a region that faces unique healthcare challenges and where laboratory testing is a crucial plank of healthcare outcomes, the continuing education of current and future healthcare professionals in the science of laboratory medicine is a core theme of our company’s mission”, said Abdul Hamid Oubeisi, CEO of NRL.
“The continuing innovation and advancements in laboratory testing and technology are remarkable and it is our mission and duty to educate the laboratory professionals, physicians and patients about these exciting changes. These advancements will only serve to facilitate faster diagnostic and more precise treatment decisions, which should ultimately increase the quality of care for our patients. As a partner of LabCorp, the world’s leading healthcare diagnostics company, and having one of the largest teams of locally-present laboratory experts, NRL is in the best position to assume its role as a thought leader in the region”, said Dr. Basel Altrabulsi, Chief Medical Officer
of NRL.
During MEDLAB, in cooperation with their partner LabCorp from the USA, NRL hosted a workshop of Coagulation Reference Testing, led by Michael Taylor, M.S., Associate Vice President of Laborator y Corporation of America – Colorado Coagulation. Special Coagulation is one of NRL’s Centers of Excellence that the company is working to establish during 2017.
Dr. Basel Altrabulsi, NRL’s Chief Medical Officer, also presented at the MEDLAB Conference, giving a lecture on ‘Managing the anatomic pathology laboratory’ and ‘Update on molecular tests and their value in evaluating challenging lesions of thyroid FNAs.